|
1
|
Vendramini-Costa DB and Carvalho JE:
Molecular link mechanisms between inflammation and cancer. Curr
Pharm Des. 18:3831–3852. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma A, Qi S and Chen H: Antioxidant therapy
for prevention of inflammation, ischemic reperfusion injuries and
allograft rejection. Cardiovasc Hematol Agents Med Chem. 6:20–43.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carreira PE: Pulmonary hypertension in
autoimmune rheumatic diseases. Autoimmun Rev. 313–320. 2004.
View Article : Google Scholar
|
|
4
|
Fialkow L, Wang Y and Downey GP: Reactive
oxygen and nitrogen species as signaling molecules regulating
neutrophil function. Free Radic Biol Med. 42:153–164. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geronikaki AA and Gavalas AM: Antioxidants
and inflammatory disease: synthetic and natural antioxidants with
anti-inflammatory activity. Comb Chem High Throughput Screen.
9:425–442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gasparini C and Feldmann M: NF-κB as a
target for modulating inflammatory responses. Curr Pharm Des.
18:5735–5745. 2012.
|
|
7
|
Lawrence T: The nuclear factor NF-kappaB
pathway in inflammation. Cold Spring Harb Perspect Biol.
1:a0016512009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siomek A: NF-κB signaling pathway and free
radical impact. Acta Biochim Pol. 59:323–331. 2012.
|
|
9
|
Temkin V and Karin M: From death receptor
to reactive oxygen species and c-Jun N-terminal protein kinase: the
receptor-interacting protein 1 odyssey. Immunol Rev. 220:8–21.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morgan MJ and Liu ZG: Crosstalk of
reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115.
2011.
|
|
11
|
Gloire G, Legrand-Poels S and Piette J:
NF-kappaB activation by reactive oxygen species: fifteen years
later. Biochem Pharmacol. 72:1493–1505. 2006.PubMed/NCBI
|
|
12
|
Fylaktakidou KC, Hadjipavlou-Litina DJ,
Litinas KE and Nicolaides DN: Natural and synthetic coumarin
derivatives with anti-inflammatory/antioxidant activities. Curr
Pharm Des. 10:3813–3833. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Witaicenis A, Seito LN and Di Stasi LC:
Intestinal anti-inflammatory activity of esculetin and
4-methylesculetin in the trinitrobenzenesulphonic acid model of rat
colitis. Chem Biol Interact. 186:211–218. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwon OS, Choi JS, Islam MN, Kim YS and Kim
HP: Inhibition of 5-lipoxygenase and skin inflammation by the
aerial parts of Artemisia capillaris and its constituents.
Arch Pharm Res. 34:1561–1569. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prabakaran D and Ashokkumar N: Protective
effect of esculetin on hyperglycemia-mediated oxidative damage in
the hepatic and renal tissues of experimental diabetic rats.
Biochimie. 95:366–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Subramaniam SR and Ellis EM:
Esculetin-induced protection of human hepatoma HepG2 cells against
hydrogen peroxide is associated with the Nrf2-dependent induction
of the NAD(P)H: Quinone oxidoreductase 1 gene. Toxicol Appl
Pharmacol. 250:130–136. 2011. View Article : Google Scholar
|
|
17
|
Kim SH, Kang KA, Zhang R, et al:
Protective effect of esculetin against oxidative stress-induced
cell damage via scavenging reactive oxygen species. Acta Pharmacol
Sin. 29:1319–1326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee CR, Shin EJ, Kim HC, et al: Esculetin
inhibits N-methyl-D-aspartate neurotoxicity via glutathione
preservation in primary cortical cultures. Lab Anim Res.
27:259–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leung KN, Leung PY, Kong LP and Leung PK:
Immunomodulatory effects of esculetin (6,7-dihydroxycoumarin) on
murine lymphocytes and peritoneal macrophages. Cell Mol Immunol.
2:181–188. 2005.PubMed/NCBI
|
|
20
|
Park C, Jin CY, Kim GY, et al: Induction
of apoptosis by esculetin in human leukemia U937 cells through
activation of JNK and ERK. Toxicol Appl Pharmacol. 227:219–228.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park C, Jin CY, Kwon HJ, et al: Induction
of apoptosis by esculetin in human leukemia U937 cells: roles of
Bcl-2 and extracellular-regulated kinase signaling. Toxicol In
Vitro. 24:486–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kyung J, Kim D, Park D, et al: Synergistic
anti-inflammatory effects of Laminaria japonica fucoidan and
Cistanche tubulosa extract. Lab Anim Res. 28:91–97. 2012.
View Article : Google Scholar
|
|
23
|
Lee SH, Kim DW, Eom SA, et al: Suppression
of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin
inflammation in mice by transduced Tat-Annexin protein. BMB Rep.
45:354–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sekiya K, Okuda H and Arichi S: Selective
inhibition of platelet lipoxygenase by esculetin. Biochim Biophys
Acta. 713:68–72. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang CS, Yuk JM and Jo EK: The role of
nitric oxide in mycobacterial infections. Immune Netw. 9:46–52.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rimoldi JM and Chimote SS: Inhibition on
inducible nitric oxide synthase. Curr Opin Drug Discov Devel.
1:183–191. 1998.PubMed/NCBI
|
|
27
|
Murakami A and Ohigashi H: Targeting NOX,
INOS and COX-2 in inflammatory cells: chemoprevention using food
phytochemicals. Int J Cancer. 121:2357–2363. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wadleigh DJ, Reddy ST, Kopp E, Ghosh S and
Herschman HR: Transcriptional activation of the cyclooxygenase-2
gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem.
275:6259–6266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kanno S, Shouji A, Tomizawa A, et al:
Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced
endotoxin shock in mice and nitric oxide production in RAW 264.7
macrophages. Life Sci. 78:673–681. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin WJ and Yeh WC: Implication of
Toll-like receptor and tumor necrosis factor alpha signaling in
septic shock. Shock. 24:206–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dayer JM: The process of identifying and
understanding cytokines: from basic studies to treating rheumatic
diseases. Best Pract Res Clin Rheumatol. 18:31–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guha M and Mackman N: LPS induction of
gene expression in human monocytes. Cell Signal. 13:85–94. 2001.
View Article : Google Scholar
|
|
33
|
Pearlman DS: Pathophysiology of the
inflammatory response. J Allergy Clin Immunol. 104:S132–S137. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Beutler B and Cerami A: The biology of
cachectin/TNF-α primary mediator of the host response. Annu Rev
Immunol. 7:625–655. 1989.
|
|
35
|
Blatteis CM, Li S, Li Z, Perlik V and
Feleder C: Signaling the brain in systemic inflammation: the role
of complement. Front Biosci. 9:915–931. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Aggarwal BB and Natarajan K: Tumor
necrosis factors: developments during the last decade. Eur Cytokine
Netw. 7:93–124. 1996.PubMed/NCBI
|
|
37
|
Moynagh PN: The NF-kappaB pathway. J Cell
Sci. 118:4589–4592. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sarkar FH, Li Y, Wang Z and Kong D:
NF-kappaB signaling pathway and its therapeutic implications in
human diseases. Int Rev Immunol. 27:293–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Makarov SS: NF-kappaB as a therapeutic
target in chronic inflammation: recent advances. Mol Med Today.
6:441–448. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Islam MN, Choi RJ, Jin SE, et al:
Mechanism of anti-inflammatory activity of umbelliferone
6-carboxylic acid isolated from Angelica decursiva. J
Ethnopharmacol. 144:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jung WK, Choi I, Lee DY, et al: Caffeic
acid phenethyl ester protects mice from lethal endotoxin shock and
inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible
nitric oxide synthase expression in RAW 264.7 macrophages via the
p38/ERK and NF-kappaB pathways. Int J Biochem Cell Biol.
40:2572–2582. 2008. View Article : Google Scholar
|
|
42
|
Harris J, Olière S, Sharma S, et al:
Nuclear accumulation of cRel following C-terminal phosphorylation
by TBK1/IKK epsilon. J Immunol. 177:2527–2535. 2006. View Article : Google Scholar : PubMed/NCBI
|
